The Economic Burden of Alopecia Areata: Evidence from a Survey in Norway and Sweden

    February 2026 in “ Acta Dermato Venereologica
    Sofia Löfvendahl, Frida Hjalte, Ida Haggren, Flora Balieva, Flora Balieva, Tsen‐Fang Tsai
    TLDR Alopecia areata causes significant financial strain and dissatisfaction with treatment in Norway and Sweden.
    This study surveyed 329 adults with alopecia areata (AA) in Norway and Sweden to assess its economic burden. The annual mean total cost of AA was €7,677 in Norway and €12,582 in Sweden, with indirect costs like reduced productivity comprising 61-64% of the total. Individuals bore significant out-of-pocket expenses, covering 65% of direct costs in Norway and 50% in Sweden. There was notable dissatisfaction with treatment and healthcare support, and the use of systemic therapies was low, likely due to reimbursement issues. The study underscores the significant economic burden of AA and the need for better therapies and healthcare support.
    Discuss this study in the Community →

    Research cited in this study

    14 / 14 results